Investigating the use of surgical mesh in breast reconstruction after mastectomy
Randomized Feasibility Trial for Mesh in Pre-Pectoral Reconstruction
This study is looking at how using surgical mesh during breast reconstruction after a mastectomy affects recovery and satisfaction, and it's for women who are considering this procedure.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California Los Angeles NIH-funded |
| Lab location | 1 site (Los Angeles, United States) |
| Project ID | NIH-10553174 on NIH RePORTER |
What this research studies
This research explores the feasibility of using surgical mesh devices in pre-pectoral breast reconstruction, which is a procedure performed after mastectomy to restore the breast's appearance. The study aims to compare the outcomes of patients receiving implants with and without the use of mesh, focusing on both physical and psychological recovery. By conducting a randomized trial, the researchers hope to gather robust data on the risks and benefits associated with this approach, which has not been thoroughly evaluated in prior studies. Patients participating in this trial will be closely monitored to assess their satisfaction and overall health outcomes following the procedure.
Who could benefit from this research
Good fit: Ideal candidates for this research are women who are undergoing mastectomy due to breast cancer and are considering breast reconstruction.
Not a fit: Patients who have already undergone breast reconstruction or those not seeking reconstruction after mastectomy may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved breast reconstruction techniques that enhance patient satisfaction and reduce complications.
How similar studies have performed: While there have been small studies on submuscular reconstructions, this approach using mesh in pre-pectoral reconstruction is relatively novel and has not been extensively tested in a randomized trial format.
Where this research is happening
Los Angeles, United States
- University of California Los Angeles — Los Angeles, United States (Active)
Researchers
- Principal investigator: Delong, Michael Ray — University of California Los Angeles
- Study coordinator: Delong, Michael Ray
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.